Insight Wealth Strategies LLC Trims Stock Holdings in Liquidia Corporation $LQDA

Insight Wealth Strategies LLC reduced its stake in Liquidia Corporation (NASDAQ:LQDA) by 12.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 124,067 shares of the company’s stock after selling 18,335 shares during the period. Liquidia comprises approximately 1.0% of Insight Wealth Strategies LLC’s investment portfolio, making the stock its 29th largest position. Insight Wealth Strategies LLC’s holdings in Liquidia were worth $9,841,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of the stock. GSA Capital Partners LLP increased its position in shares of Liquidia by 63.6% during the fourth quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after acquiring an additional 24,555 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Liquidia by 63.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 58,265 shares of the company’s stock worth $2,199,000 after acquiring an additional 22,592 shares during the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Liquidia in the 4th quarter worth approximately $709,000. WCG Wealth Advisors LLC lifted its holdings in shares of Liquidia by 98.2% in the 4th quarter. WCG Wealth Advisors LLC now owns 54,411 shares of the company’s stock worth $1,877,000 after acquiring an additional 26,957 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Liquidia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock worth $138,439,000 after purchasing an additional 52,671 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Insider Buying and Selling

In related news, insider Sanjeev Khindri sold 1,185 shares of the company’s stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $71.51, for a total transaction of $84,739.35. Following the sale, the insider directly owned 65,947 shares in the company, valued at approximately $4,715,869.97. This represents a 1.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Jason Adair sold 688 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $87.53, for a total transaction of $60,220.64. Following the sale, the insider owned 216,438 shares in the company, valued at $18,944,818.14. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 1,781,861 shares of company stock worth $124,407,112 over the last ninety days. Company insiders own 25.60% of the company’s stock.

Liquidia Stock Down 3.3%

Shares of NASDAQ LQDA opened at $88.05 on Wednesday. The stock has a market cap of $7.83 billion, a P/E ratio of 628.97 and a beta of 0.58. The business’s fifty day simple moving average is $77.76 and its 200-day simple moving average is $54.51. Liquidia Corporation has a 12-month low of $21.15 and a 12-month high of $93.61. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDA) last released its earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $171.68 million for the quarter, compared to analyst estimates of $168.48 million. As a group, equities analysts predict that Liquidia Corporation will post 3.02 EPS for the current fiscal year.

Wall Street Analyst Weigh In

LQDA has been the subject of several research reports. Zacks Research upgraded shares of Liquidia from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Oppenheimer set a $75.00 price target on Liquidia in a research note on Friday, June 5th. BTIG Research raised their price target on Liquidia from $59.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Piper Sandler set a $129.00 price objective on Liquidia in a research note on Friday, July 24th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research note on Friday, July 17th. Three research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $86.18.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).